Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Xencor, Inc.
Atavistik Bio, Inc
Mayo Clinic
Compass Therapeutics
Eli Lilly and Company
WestVac Biopharma Co., Ltd.
Whitehawk Therapeutics, Inc.
Dana-Farber Cancer Institute
NiKang Therapeutics, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
AstraZeneca
Alterome Therapeutics, Inc.
Boehringer Ingelheim
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
City of Hope Medical Center
AstraZeneca
BeOne Medicines
Daewoong Pharmaceutical Co. LTD.
Dana-Farber Cancer Institute
Primelink BioTherapeitics(ShenZhen) Limited
Whitehawk Therapeutics, Inc.
ViroMissile, Inc.
Eli Lilly and Company
Arcus Biosciences, Inc.
University of Iowa
University of Miami
Accent Therapeutics
Accent Therapeutics
Seagen Inc.
Pfizer
Memorial Sloan Kettering Cancer Center
AbbVie
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Myeloid Therapeutics